Found: 31
Select item for more details and to access through your institution.
Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Differential role of MACC1 expression and its regulation of the HGF/c-Met pathway between breast and colorectal cancer.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 5, p. 2143, doi. 10.3892/ijo.2015.2907
- By:
- Publication type:
- Article
Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-16935-4
- By:
- Publication type:
- Article
Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatment.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02765-3
- By:
- Publication type:
- Article
High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 1, p. 217, doi. 10.3390/ijms21010217
- By:
- Publication type:
- Article
Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial).
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 208, n. 2, p. 253, doi. 10.1007/s10549-024-07414-7
- By:
- Publication type:
- Article
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 225, doi. 10.1007/s10549-023-07144-2
- By:
- Publication type:
- Article
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial).
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 253, doi. 10.1007/s10549-023-06911-5
- By:
- Publication type:
- Article
Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 2, p. 353, doi. 10.1007/s10549-018-4933-5
- By:
- Publication type:
- Article
Dexamethasone dose-dependently prevents taxane-associated acute pain syndrome in breast cancer treatment.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 6, p. 1, doi. 10.1007/s00520-023-07852-x
- By:
- Publication type:
- Article
Impact of systemic dexamethasone dosage on docetaxel-induced oral mucositis in patients with breast cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37285-9
- By:
- Publication type:
- Article
High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36264-4
- By:
- Publication type:
- Article
Clinical Implications of Occult Metastases and Isolated Tumor Cells in Sentinel and Non-Sentinel Lymph Nodes in Early Breast Cancer Patients: Serial Step Section Analysis with Long-Term Follow-Up.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 4, p. 1160, doi. 10.1245/s10434-011-2085-5
- By:
- Publication type:
- Article
An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0116054
- By:
- Publication type:
- Article
PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080552
- By:
- Publication type:
- Article
Clinical significance of plasma cell-free DNA mutations in <italic>PIK3CA</italic>, <italic>AKT1</italic>, and <italic>ESR1</italic> gene according to treatment lines in ER-positive breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
The Impact of Immunofunctional Phenotyping on the Malfunction of the Cancer Immunity Cycle in Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 110, doi. 10.3390/cancers13010110
- By:
- Publication type:
- Article
C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.
- Published in:
- European Journal of Human Genetics, 2015, v. 23, n. 7, p. 949, doi. 10.1038/ejhg.2014.219
- By:
- Publication type:
- Article
Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53482-x
- By:
- Publication type:
- Article
Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 1, p. 24, doi. 10.3892/mco.2017.1265
- By:
- Publication type:
- Article
The ubiquitin E3 ligase activity of BRCA1 and its biological functions.
- Published in:
- Cell Division, 2008, v. 3, p. 1, doi. 10.1186/1747-1028-3-1
- By:
- Publication type:
- Article
Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 5, p. 1039, doi. 10.1007/s00280-009-0961-5
- By:
- Publication type:
- Article
Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87645-6
- By:
- Publication type:
- Article
Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
New evidence about thyroid cancer prevalence: prevalence of thyroid cancer in younger and middle-aged Japanese population.
- Published in:
- Endocrine Journal, 2013, v. 60, n. 4, p. 501, doi. 10.1507/endocrj.ej12-0420
- By:
- Publication type:
- Article
Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.865024
- By:
- Publication type:
- Article
Evaluation of a novel medical device for pegfilgrastim administration.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1763, doi. 10.1111/cas.15335
- By:
- Publication type:
- Article
Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.
- Published in:
- Cancer Science, 2016, v. 107, n. 4, p. 491, doi. 10.1111/cas.12897
- By:
- Publication type:
- Article
Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer.
- Published in:
- Cancer Science, 2015, v. 106, n. 11, p. 1582, doi. 10.1111/cas.12813
- By:
- Publication type:
- Article
Factors involved in early lenvatinib dose reduction: a retrospective analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 3, p. 746, doi. 10.1007/s12282-020-01212-x
- By:
- Publication type:
- Article